Остеопороз у лиц мужского пола и прогностическая значимость факторов риска при переломах разной локализации
Диссертация
Абсолютное число мужчин с различными переломами, происходящими вследствие остеопороза, неуклонно растет в связи со «старением» популяции. Существует мнение, что катастрофическая глобальная эпидемия остеопороза неизбежна, если не будут приняты решительные шаги для профилактики этого заболевания. Риск перелома для 50-летнего мужчины в США составляет: 2,5% — переломы предплечья, 5% — переломы… Читать ещё >
Содержание
- СПИСОК СОКРАЩЕНИЙ
- Глава 1. ОБЗОР ЛИТЕРАТУРЫ
- 1. 1. Современные представления о костном метаболизме
- 1. 2. Остеопороз: определение, классификация, диагностика
- 1. 3. Распространенность остеопороза и переломов у лиц мужского пола
- 1. 4. Факторы риска остеопороза и переломов
- 1. 4. 1. Генетические факторы риска
- 1. 4. 2. Вторичные факторы риска остеопороза и переломов
- 1. 5. Профилактика и лечение остеопороза у мужчин
- Глава 2. МАТЕРИАЛЫ И МЕТОДЫ ИССЛЕДОВАНИЯ
- 2. 1. Программа исследования
- 2. 2. Объекты исследования
- 2. 3. Анкетирование
- 2. 4. Денситометрическое исследование
- 2. 5. Рентгенологическое обследование
- 2. 6. Статистический анализ результатов
- Глава 3. РЕЗУЛЬТАТЫ ИССЛЕДОВАНИЯ
- 3. 1. Особенности накопления и физиологического снижения минеральной плотности костной ткани у лиц мужского пола в разные возрастные периоды
- 3. 2. Распространенность снижения минеральной плотности костной ткани у лиц мужского пола разного возраста
- 3. 3. Анализ частоты переломов разной локализации у лиц мужского пола разного возраста
- 3. 4. Взаимосвязь снижения минеральной плотности костной ткани у лиц мужского пола с факторами риска
- Глава 4. ОБСУЖДЕНИЕ РЕЗУЛЬТАТОВ
Список литературы
- Беневоленская Л.И. Остеопороз актуальная проблема медицины. Остеопороз и остеопатии. 1998. № 1. С. 4−7.
- Беляева А.Г., Чижов П. А. Связь проявлений остеопороза и хронического обструктивного бронхита у мужчин. Ревматология. 2002. № 4. С. 25- 27.
- Беневоленская Л.И. Руководство по остеопорозу. М. БИНОМ. Лаборатория знаний, 2003, 523 с.
- Беневоленская Л.И., Афиногенова С. А. Генетика остеопороза: исследование значимости генетических факторов в детерминации остеопороза. Остеопороз и остеопатии. 1999. № 2. С 23−25.
- Беневоленская Л.И., Лесняк О. М. Остеопороз. Диагностика, профилактика и лечение. М. ГЭОТАР-Медиа, 2010. 270 с.
- Бурдыгина Н.В. Минеральная плотность костной ткани по данным двухфотонной рентгеновской денситометрии и нейтронно-активационного анализа у жителей гг. Москвы и Обнинска: Автореф. дисс. канд. мед. наук. М., 2000.
- Дедов И.И., Рожинская Л. Я., Марова Е. И. Остеопороз, диагностика, принципы профилактики и лечения: Метод, пособие для врачей. М., 1999. 63 с.
- Древаль A.B., Марченкова Л. А., Полякова Е. Ю. Вторичный стероидный остеопороз: патогенез, диагностика, лечение. Учебное пособие. М. 2003. С. 32.
- Ершова О.Б. Клинико-эпидемиологическая характеристика остеопороза: Автореф. дисс. д-ра. мед. наук. Ярославль, 1998.
- Казимирко В.К., Коваленко В. Н., Мальцев В. И. Остеопороз: патогенез, клиника, профилактика и лечение. Киев. МОРИОН. 2006. 159 с.
- Корнилов Н.В., Михайлов С. А., Малинин В. Л. Определение минеральной плотности костной ткани подростков и юношей Санкт-Петербургас целью ранней профилактики остеопороза. Травматология и ортопедия России. 2004. № 1. С. 36−43.
- Короткова Т.А. Характеристика костной ткани подростков по оценке показателей минерализации: Автореф. дисс. канд. мед. наук. М. 2007.
- Кочеткова Е. А., О. Ю. Бубнов, Васильева Т. Г. Ювенильный ос-теопороз: миф или реальность? Тихоокеанский медицинский журнал. 2005. № 1.С. 5−9.
- Лазебник Л.Б., Назаренко И. В., Шварц Г. Я. Эпидемиология остеопороза, профилактика, варианты клинического течения и его осложнений. Методическое пособие. М., 2003. С. 8 -11.
- Малинин В.Л. Сравнение минеральной плотности костной ткани поясничных позвонков петербуржцев и американцев: Автореф. дисс. канд. мед. наук. СПб., 2003.
- Меркулов В.Н., Родионова С. С., Ильина В. К. и др. Повреждения грудного и поясничного отделов позвоночника на фоне ювенильного остеопороза. Вестник травматологии и ортопедии. 2002. № 1. С.7−11.
- Михайлов С.А., Малинин В. Л. Диагностика, лечение и профилактика остеопороза позвоночника у подростков. Актуальные вопросы диагностики и лечения остеопороза. СПб., 1998. С. 85−90.
- Михайлов Е.Е., Короткова Т. А., Дёмин Н. В. Частота дефицита витамина D среди подростков московской выборки. Научно-практическая ревматология. 2005. № 1. С. 85−90.
- Михайлов С.А., Малинин В. Л., Мазуренко О. Г. Минеральная плотность костной ткани в популяционной выборке у лиц мужского пола 1516 лет. Материалы II конференции «Проблема остеопороза в травматологии и ортопедии». М. 2003. С. 74−75.
- Мищенко Е.Б. Оценка значимости внешних и внутренних факторов риска развития остеопороза: Автореф. дисс. канд. мед. наук. С-Пб., 2007.
- Морозов А.К., Зайчик В. Е., Шевладзе З. Н. и др. Минеральная плотность костной ткани в популяционной выборке лиц от 15 до 55 лет по данным двухэнергетической денситометрии. Методические указания. М., 2000.
- Насонов Е. Л. Вторичный остеопороз: патогенез и клиническое значение при воспалительных заболеваниях суставов. Остеопороз и остеопатии. 1998. № 1.С. 18−22.
- Поворознюк В.В. Возрастные аспекты структурно-функционального состояния костной ткани населения Украины. Остеопороз и остеопатии. 2000. № 1. С. 15−22.
- Риггз Б. Л, Мелтон Л. Д. Остеопороз. Этиология, диагностика, лечение. М. СПб.: ЗАО Издательство БИНОМ, «Невский диалект». 2000. 560 с.
- Родионова С.С., Морозов А. К. Возможности и ошибки неинва-зивной количественной оценки массы костной ткани для диагностики остео-пороза. Остеопороз и остеопатии. 2005. № 1. С. 41−44.
- Рожинская Л .Я. Системный остеопороз: Практическое руководство для врачей. М., 2000. 196 с.
- Торопцова Н.В., Беневоленская Л. И. Распространенность остео-поротических переломов позвонков у женщин с остеопенией. Материалы III Российского симпозиума по остеопорозу. СПб., 2000. С. 86.
- Турилина Е.В. Минеральная плостность и морфометрические параметры поясничных позвонков у людей 5−85 лет: Автореф. дисс. канд. мед. наук. Курган. 2007.
- Фаламеева О.В. Остеопороз и остеопения в детском, подростковом и юношеском возрасте. Хирургия позвоночника. 2008. № 2. С. 15−22.
- Франке Ю., Рунге Г. Остеопороз. М.: Медицина, 1995. 304 с.
- Цейтлин О.Я. Распространенность, диагностика и профилактик-тика остеопороза и остеопенических переломов (на примере популяции Самарской области): Автореф. дисс. докт. мед. наук. Самара, 2002.
- Щеплягина J1.A., Моисеева Т. Ю., Коваленко М. В. Остеопения у детей, профилактика и коррекция. Пособие для врачей. М., 2005.
- Aarden Е., Wassenaar A., Aiblas М., et al. Immunocytochemical demonstration of extracellular matrix proteins in isolated osteocytes // Histochem. Cell Biol. 1996. Vol. 106. № 5. P. 495−501.
- Abu E.O., Horner A., Kusec J.T., et al. The localization of androgen receptors in human bone. J. Clin. Endocrinol. Melab. 1997. V. 82. P. 3493−3497.
- Adachi Y., Shiota E., Matsumata Т., et al. Osteoporosis after gastrectomy: bone mineral density of lumbar spine assessed by dual-energy X-ray absorptiometry. Calcif Tissue Int. 2000. Vol. 66. P. 119−122.
- Ahmed A.I., Blake G.M., Rymer J.M., et al. Screening for osteopenia and osteoporosis: do the accepted normal ranges lead to overdiagnosis? Osteoporos Int. 1997. Vol. 7. P. 432−438.
- Alexander C. Idiopathic osteoporosis: an evolutionary dysadaptation? Ann. Rheum. Dis. 2001. Vol. 60. P. 554−558.
- Amin S., Zhang Y., Sawin C.T., et al. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framing-ham study. Ann. Internal Med. 2000. V. 133. P. 951−963.
- Amory J.K., Watts N.B., Easley K.A., et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J. Clinic. Endocrin. Metab. 2009. V. 89. P. 503−510.
- Anderson F.H., Francis R.M., Peaston R.T., et al. Androgen supplementation in cugonadal men with osteoporosis: effects of six months treatment on markers, of bone formation and resorbtion. J. Bone Miner. Res. 1997. V. 12. N 3. P. 472−478.
- Bacon W.E., Smith G.S., Baker S.P. Geographic variation in the occurrence of hip fractures among the elderly white US population. Amer. J. Public Health. 1989. V. 79. P. 1556−1558.
- Bass E., French D.D., Bradham D.D., et al. Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann. Epidemiol. 2007. V. 17. P. 514 519.
- Barrett-Connor E., Mueller J.E., von Muhlen D.G., et al. Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study. J. Clinic. Endocrin. Metab. 2010. V. 85. P. 219−223.
- Barrett-Connor E., Siris E.S., Wehren L.E. Osteoporosis and fracture risk in women of different ethnic groups. J. Bone Miner. Res. 2005. Vol. 20. P. 185−194.
- Bates D.W., Black D.M., Cummings S.R. Clinical use of bone densitometry: clinical applications. JAMA. 2002. Vol. 288. P. 1898−1900.
- Bendavid J.Sh., Barrett-Connor E. Factors associated with bone mineral density in middle-aged men. Bone Miner. Res. 1996. V. 11. N 8. P. 11 851 190.
- Benito M., Gomberg B., Wehrli R.H., et al. Deterioration of trabecular architecture in hypogonadal men. J. Clinic. Endocrin. Metab. 2003. V. 88. P. 1497−1502.
- Bikle D.D. Bone disease in alcohol abuse. Annals of Inter. Med. 1985. V. 103. N l.P. 42−48.
- Bilezikian J.P. Osteoporosis in men. J. Clinic. Endocrin. Metab. 1999. V. 84. P. 3431−3434.
- Boonen S., Vanderschueren D. Bone loss and osteoporotic fracture occurrence in aging men. In Textbook of Men’s Health, pp 455−462. Eds B Lunenfeld & L Gooren. New York, NY: Parthenon Publishing Group, 2002.
- Boonen S., Vanderschueren D., Cheng X.G., et al. Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitami-nosis D- and androgen deficiency-induced bone resorption. J. Bone Mineral Res. 1997. V. 12. P. 2119−2126.
- Bouillon R., Bex M., Vanderschueren D., et al. Estrogens are essential for male pubertal periosteal bone expansion. J. Clinic. Endocrin. Metab. 2004. V. 89. P. 6025−6029.
- BrennanR.M., Wactawski-Wende J., Crespo C.J., et al. Factors associated with treatment initiation after osteoporosis screening. Am. J. Epidem. 2004. V. 160. № 5. P. 475−483.
- Bronner F. Calcium and osteoporosis. Am. J. Clin. Nutr. 1994. V. 60. N6. P. 831−836.
- Brown J.P., Josse R.G. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 2002. Vol. 167. P. 90 100.
- Buckwalter J.A., Glimcher M.J., Cooper R.R., et al. Bone biology: structure, blood supply, cells, matrix, and mineralization. Instr. Course Lect. 1996. Vol. 45. P. 371 -386.
- Burger H., de Laet C.E., van Daele P.L., et al. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Americ. J. Epidem. 1998. V. 147. P. 871−879.
- Cadarette S.M., Mclsaac W.J., Hawker G.A. The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing. Osteoporos Int. 2004. Vol.15. P. 361−366.
- Cannan R., Gold E., Lewis-Barnet N. Hip length and femoral bone mineral density in girls aged 4−15 years: relationships with weight, height, fat mass and lean tissue mass. Bone. 1995. Vol. 16. № 1, Suppl. P. 147.
- Castro da Rocha F.A., Ribeiro A.R. Low incidence of hip fractures in an equatorial area. Osteoporosis Int. 2003. V. 14. P. 496−499.
- Carani C., Qin K., Simoni M., et al. Effect of testosterone and estradiol in a man with aromatase deficiency. New England J. Med. 1997. V. 337. P. 91−95.
- Carlsen C., Sorensen T., Eriksen E. Low S-estradiol levels are prevalent in males diagnosed with primary osteoporosis. Osteoporosis Int. 2000. V 11. Supp.2. S155.
- Carlsen C.G., Soerensen H.T., Eriksen E.F. Prevalence of low serum estradiol levels in male osteoporosis. Osteoporosis Int. 2000. V. 11. P. 697−701.
- Cassidy J.T. Osteopenia and osteoporosis in children. Clin. Exp. Rheumatol. 1999. Vol. 17. N 2. P. 245−50.
- Cauley J.A., Zmuda J.M., Wisniewski S.R. Bone mineral density and prevalent vertebral fractures in men and women. Osteoporos Int. 2010. Vol. 15. P. 32−37.
- Center J.R., Nguyen T.V., Schneider D., et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999. V. 353. P. 878−882.
- Chariyalertsak S., Suriyawongpisal P., Thakkinstain A. Mortality after hip fractures in Thailand. Int. Orthop. 2001. V. 25. P. 294−297.
- Cheng N., Green M. E. Osteoporosis screening for men: are family physicians following the guidelines? Can. Fam. Physician. 2008. V. 54. P. 1140 -1141.
- Clark M.K., Sowers M.F., Dekordi F., et al. Bone mineral density and fractures among alcohol-dependent women in treatment and in recovery. Osteoporos Int. 2003. Vol. 14. P. 396−403.
- Compston J. Local biosynthesis of sex steroids in bone. J. Clinic.Endocrin. Metab. 2002. V. 87. P. 5398−5400.
- Cree M., Soskolne C.L., Belseck E., et al. Mortality and institutionalization following hip fracture. J. Am. Geriatr. Soc. 2000. V. 48. P. 283−288.
- Daniell H.W. Osteoporosis after orchiectomy for prostate cancer. J. Urol. 1997. V. 157. N 2. P. 439−444.
- Davison S.L., Bell R., Donath S., et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J. Clinic. Endocrin. Me-tab. 2005. V. 90. P. 3847−3853.
- Dawson H.B., Harris S.S., Dallal G.E. Plasma calcidiol season, and semm parathyroid hormone concentrations in healthy elderly men and women. Am. J. Clin. Nulr. 1997. V. 65. N 1. P. 67−71.
- Dell-Rio L., Carrascosa A., Pons F., et al. Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: changes related to age, sex and puberty. Pediatr. Res. 1994. Vol. 35. № 3. P.362−366.
- Donaldson L.J., Cook A., Thomson R.G. Incidence of fractures in a geographically defined population. J. Epidemiol. Comm. Health. 1990. V. 44. P. 241−245.
- Eriksson A.L., Lorentzon M., Vandenput L., et al. Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. J. Clin. Endocrinol. Metab. 2009. V. 94. P. 1033 1041.
- Evans S.F., Davie M.W.J. Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men Ann. Rheum. Dis. 2000. V.59. P. 269 275.
- Falahati-Nini A., Riggs B.L., Atkinson E.J., et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J. Clinic. Investig. 2010. V. 106. P. 1553−1560.
- Faustini-Fustini M., Rochira V., Carani C. Oestrogen deficiency in men: where are we today? Europ. J. Endocrin. 1999. V. 140. P. 111−129.
- Feldman H.A., Longcope C., Derby C.A., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J. Clinic. Endocrin. Metab. 2002. V. 87. P. 589−598.
- Finkelstein J.S., Klibanski A., Neer R.M. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J. Clinic. En-docrin. Metab. 1996. V. 81. P. 1152−1155.
- Finkelstein J.S., Klibanski A., Neer R.M. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. Clin. Endocrinol. Melab. 1996. V. 81. N. 3. P. 1152−1155.
- Finkelstein J.S., Neer R.M., Biller B.M., et al. Osteopenia in men with a history of delayed puberty. New England J. Medic. 1992. V. 326. P. 600 604.
- Francis R.M. Pathogenesis and Management of Osteoporosis in Men, Report on 15"' joint meeting of the BES, Satellite symposium on testosterone replacement therapy, 25 march 1996.
- Gaudiy J., Deslandre J., Mazda K., et al. Idiopathic juvenile osteoporosis: a new observation. Arch. Pediatr. 1999. Vol. 6. № 8. P.859−862.
- Gcnnari L., Gonnelli S., Becherini L., el al. Gone loss and bone turnover in aeed men: hormonal and genetic determinants. Osteoporosis International. 2000. V. 11. Supp.2. S147.
- Gennari L., Masi L., Merlotti D., et al. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J. Clinic. Endocrin. Metab. 2004. V. 89. P. 2803−2810.
- Gennari L., Merlotti D., Martini G., et al. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J. Clinic. Endocrin. Metab. 2003. V. 88. P. 5327−5333.
- Gennari L., Bilezikian J.P. Osteoporosis in men. Endocrinol. Metab. Clin. North. Am. 2007. V. 36. P. 399−419.
- Gooren L.J., Toorians A.W. Significance of oestrogens in male (patho)physiology. Ann. Endocrin. 2003. V. 64. P. 126−135.
- Greenspan S.I., Openhcim D.S. Impotence of gonadal steroids to bone mass in men with hyperpolactinemic hypogonadism. Ann. Inlem. Med. 2009. V. 110. N7. P. 526−531.
- Greendale G.A., Edelstein S., Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. J. Bone Miner. Res. 1997. Vol. 12. P. 1833−1843.
- Hagino H., Katagiri H., Okano T., et al. Increasing incidence of hip fracture in Tottori Prefecture, Japan: trend from 1986 to 2001. Osteoporos Int. 2005. V. 16. P. 1963−1968.
- Hasegawa Y., Suzuki S., Wingstrand H. Risk of mortality following hip fracture in Japan. J. Orthop. Sci. 2007. V. 12. P. 113−117.
- Harman S.M., Metter E.J., Tobin J.D., et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J. Clinic. Endo-crin. Metab. 2001. V. 86. P. 724−731.
- Herrmann B.L., Sailer B., Janssen O.E., et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J. Clinic. Endocrin. Metab. 2002. V. 87. P. 5476−5484.
- Hernandez J.L., Olmos J.M., Alonso M.A., et al. Trend in hip fracture epidemiology over a 14-year period in a Spanish population. Osteoporos Int. 2006. V. 17. P. 464−470.
- Hui S.L., Slemenda C.W., Johnston C.C. Age and bone mass as predictors of fracture in a prospective study. J. Clin. Invest. 1988. Vol. 81. P. 18 041 809.
- Jackson J.A. Osteoporosis in men. In: F. Favus (Ed,) Primer on metabolic bone diseases and disorders of mineral metabolism. Raven Press, New York. 1993. P. 162−164.
- Johnell O., Kanis J.A., Oden A., et al. Predictive value of BMD for hip and other fractures. J Bone Miner. Res. 2005. V. 20. P. 1185−1194.
- Johnell O., Kanis J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006. V. 17. P. 1726−1733.
- Jonsson B.Y., Siggeirsdottir K., Mogensen B., et al. Fracture rate in a population-based sample of men in Reykjavik. Acta Orthop Scand 2004. V. 75. P. 195−200.
- Kanis J.A., Borgstrom F., De Laet C. Assessment of fracture risk. Os-teop. Int. 2005. Vol. 16. P. 581−589.
- Kanis J.A., Johnell O., Oden A., et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008. V. 19v/ P. 385−397.
- Katznelson L. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. Clin. Endocrinol. Metab. 1996. V. 81. N 12. P. 4358−4365.
- Kelepouris N., Harper K.D., Gannon F., el al. Sever osteoporosis in men. Ann. Inter. Med. 1995. V. 123. N 6. P. 452−460.
- Kelley G.A., Kelley K.S., Tran Z.V. Exercise and bone mineral density in men: a meta-analysis. J. Appl Physiol. 2000. Vol. 88. P. 1730−1736.
- Kenny A.M., Prestwood K.M., Marcello K.M., et al. Determinants of bone density in healthy older men with low testosterone levels. J. Geront. Biolog. Seien. Med. Scienc. 2000. V. 55. P. 492−497.
- Khan A. A., Hodsman A. B., Papaioannou A., et al. Management of osteoporosis in men: an update and case example. Can. Med. Assoc. J. 2007. V. 176. P. 345 -348.
- Khosla S. Update in male osteoporosis. J. Clin. Endocrinol. Metab. 2010. V. 95. P. 3−10.
- Khosla S., Amin Sh., Orwoll E. Osteoporosis in men. Endocr. Rev. 2008. V. 29. P. 441 -464.
- Khosla S., Melton L.J., Atkinson E.J., et al. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J. Clinic. Endocrin. Metab. 2001. V. 86. P. 3555−3561.
- Khosla S., Melton L.J., Atkinson E.J., et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J. Clinic. Endocrin. Metab. 1998. V. 83. P. 2266−2274.
- Khosla S., Riggs B.L., Atkinson E.J., et al. Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J. Bone Miner. Res. 2006. V. 21. P. 124−131.
- Khosla S., Riggs B.L., Atkinson E.J., et al. Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men. J. Clinic. Endocrin. Metab. 2004. V. 89. P. 1808−1816.
- Kiebzak G.M., Beinart G.A., Perser K., et al. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med. 2002. V. 162. P. 2217 -2222.
- Kiel D.P., Zhang Y., Hannan M.T., et al. The effect of smoking at different life stage on bone mineral density in elderly men and women. Osteoporosis Int. 1996. V. 6. N 3. P. 240−248.
- Kurland E.S., Rosen C.J., Cosman F., et al. Insulin like growth factor -1 in men with idiopathic osteoporosis. J. Clin. Endocrinol. Metab. 1997. V. 82. N 9. P. 2799−2805.
- Lapauw B., Taes Y., Goemaere S., et al. Anthropometric and skeletal phenotype in men with idiopathic osteoporosis and their sons is consistent with deficient estrogen action during maturation. J. Clin. Endocrinol. Metab. 2009. V. 94. P. 4300−4308.
- Lau E.M., Lee J.K., Suriwongpaisal P., et al. The incidence of hip fracture in four Asian countries: the Asian Osteoporosis Study (AOS). Osteoporos Int. 2001. V. 12. P. 239−243.
- Lawrence G.R. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 2005. Vol. 115. P. 3318−3325.
- Legrand E., Hedde C., Gallois Y., et al. Osteoporosis in men: a potential role for the sex hormone binding globulin. Bone. 2001. V. 29. P. 90−95.
- Leib E.S., Lewiecki E.M., Binkley N., et al. Official positions of the International Society for Clinical Densitometry. J. Clin. Densitom. 2004. Vol. 7. P. 1−6.
- Liu H., Paige N.M., Goldzweig C.L., et al. Screening for osteoporosis in men: a systematic review for an American college of physicians guideline Ann. Intern. Med. 2008. V. 148. P. 685 701.
- Looker A.C., Orwoll E.S., Johnston C.C., et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J. Bone Mineral Res. 1997. V. 12. P. 1761−1768.
- Lorentzon M., Swanson C., Andersson N., et al. Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study. J. Bone Miner. Res. 2005. V. 20. P. 13 341 341.
- Maffei L., Murata Y., Rochira V., et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J. Clinic. Endocrin. Metab. 2004. V. 89. P. 61−70.
- Maggio D., Pacific R., Cherubini A., et al. Appendicular cortical bone loss after age 65: sex depend event? Calcif. Tissue Int. 2005. V. 56. N 5. P. 410 414.
- Mallmin H., Ljunghall S., Persson I., et al. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif. Tissue Int. 1993. V. 52. P. 269−272.
- Martin R.M., Lin C.J., Nishi M.Y., et al. Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings. J. Clinic. Endocrin. Metab. 2003. V. 88. P. 3027−3034.
- Martin A.D., Silverthorn K.G., Houston C.S., et al. The incidence of fracture of the proximal femur in two million Canadians from 1972 to 1984: projections for Canada in the year 2006. Clin Orthop Rel Res. 2006. V. 266. P. 111 118.
- Matkovic V., Fontana D., Tominac C., et al. Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone mass in adolescent females. Am. J. Clin. Nutr. 1990. Vol. 52. P.878−888.
- May H., Reader R., Murphy S., et al. Self reported tooth loss and bone mineral density in older men and women. Age Ageing. 1995. V. 24. N 3. P. 217−221.
- Meier C., Nguyen T.V., Handelsman D.J., et al. Endogenous sex hormones and incident fracture risk in older men: the dubbo osteoporosis epidemiology study. Arch. Intern. Med. 2008. V.168. P. 47 54.
- Melton L.J., Crowson C.S., O’Fallon W.M., et al. Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction. J. Bone Miner. Res. 2003. Vol. 18. P. 312−318.
- Meyer H.E., Sogaard A.J., Falch J.A., et al. Weight change over three decades and the risk of osteoporosis in men: the norwegian epidemiological osteoporosis studies (NOREPOS). Am. J. Epidemiol. 2008. V.168. P. 454 460.
- Morishima A., Grumbach M.M., Simpson E.R., et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clinic. Endocrin. Metab. 1995. V. 80. P. 3689−3698.
- Myers A.H., Robinson E.G., Van Natta M.L., et al. Hip fractures among the elderly: factors associated with in-hospital mortality. Am J Epidemiol. 1991 V. 134. N. 1128−1137.
- Naves D.M., Oneill T.W., Sitman A.J. The influence of alcohol consumption on the risk of vertebral deformity. Osteoporosis Int. 1997. V. 7. N 1. P. 65−71.
- Nguyen T.V., Sambrook P.N., Eisman J.A. Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss. J. Bone Miner. Res. 1997. V. 12. N 1. P. 124−135.
- Nguyen T.V. Risk factors for osteoporotic fractures in elderly men. Am. J. Epidemiology. 1996. V. 144. N 3. P. 255−263.
- Nguyen T.V., Kelly P.J., Sambrook P.N., et al. Lifestyle factors and bone density in the elderly: implications for osteoporosis prevention. J. Bone Miner. Res. 1994. V. 9. N 9. P. 13 399−13 346.
- Orwoll E.S. Osieoporosis in men. Osteoporosis Report. 1999. V. 15. N2. P. 32−45.
- Orwoll E.S., Blizioles M. Heterogeneity in osteoporosis. Men versus women. Rheum. Dis. Clin. North. Am. 1994. V. 20. N 3. P. 671−689.
- Orwoll E.S., Klein R.F. Osteoporosis in men. Endocr. Rev. 2005. V. 87. N1.P. 87−116.
- Papaioannou A., Morin S., Cheung A. M., et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. Can. Med. Assoc. J. 2010. V. 182. P. 1864 1873.
- Peris P., Guacabence N., Moncgal A. Aetiology and presenting symptoms in male osteoporosis. Br. J. Rheumalol. 1995. V. 34. N 10. P. 936−941.
- Picard D., Brown J.P., Rosenthall L. Ability of peripheral DXA measurement to diagnose osteoporosis as assessed by central DXA measurement. J. Clin. Densitom. 2004. Vol. 7. P. 111−118.
- Pietschmann P., Grisar J., Kudlacek S., et al. Bone turnover markers and sex hormones in men with idiopathic osteoporosis. Osteoporosis International. 2000. V. 11, Supp.2. SI65.
- Poor G. Age-related hip fractures in men: clinical spectrum and short-term outcomes. Osteoporosis. Int. 1995. V. 5. N 6. P. 419−426.
- Qaseem A., Snow V., Shekelle P., et al. Screening for osteoporosis in men: a clinical practice guideline from the american college of physicians. Ann. Intern. Med. 2008. V. 148. P. 680 684.
- Resch A., Schneider B., Berneckcr P., et al. Risk of vertebral fractures in men: relationship to density of the vertebral body. Am. J. Roentgenol. 2005. V. 164. N6. P. 1447−1450.
- Riggs B.L., Melton J., Robb R.A., et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J. Bone Miner. Res. 2004. V. 19. P. 1945−1954.115
- Riggs B.L., Melton L.J. Involutional osteoporosis. New England J. Med. 1986. V. 314. P. 1676−1686.
- Ringe J., Coster A., Dorst A., Umbach R. Alendronate treatment of established primary osteoporosis in men: two year results of a prospective comparative two-arm study. Osteoporosis International. 2000. V. 11, Supp.2. SI95.
- Rochira V., Balestrieri A., Faustini-Fustini M., et al. Role of estrogen on bone in the human male: insights from the natural models of congenital estrogen deficiency. Molec. Cell. Endocrin. 2001. V. 178. P. 215−220.
- Rochira V., Balestrieri A., Madeo B., et al. Congenital estrogen deficiency in men: a new syndrome with different phenotypes- clinical and therapeutic implications in men. Molec. Cell. Endocrin. 2002. V. 193. P. 19−28.
- Rochira V., Balestrieri A., Madeo B., et al. Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology. Eur. J. Endocrinol. 2006. V. 154. P. 175 185.
- Sanders K.M., Seeman E., Ugoni A.M., et al. Age- and gender-specific rate of fractures in Australia: a population-based study. Osteoporosis International. 1999. V. 10. P. 240−247.
- Scane A.C., Sutcliffe A.M., Francis RM. Osieoporosis in men. Baillieres din rheumaiol. 1993. V. 7. N 3. P. 589−601.
- Schwartz A.V., Kelsey J.L., Maggi S., et al. International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World
- Health Organization Program for Research on Aging. Osteoporos Int. 1999. V. 9. P. 242−253.
- Schousboe J.T., Taylor B.C., Fink H.A., et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA. 2007. V. 298. P. 629 637.
- Scopacasa F., Horowitz M., Wishart J.M., et al. The relation between bone density, free androgen index, and estradiol in men 60 to 70 years old. Bone. 2000. V. 27. P. 145−149.
- Seeman E. Do men suffer with osteoporosis. Aust. Fam. Physician. 1997. V. 26. N2. P. 135−143.
- Seeman E. Pathogenesis of bone fragility in women and men. Lancet. 2002. V. 359. P. 1841−1850.
- Seeman E. Sexual dimorphism in skeletal size, density, and strength. J. Clinic. Endocrin. Metab. 2001. V. 86. P. 4576−4584.
- Seemen E. Advance in the study of osteoporosis in men. Osteoporosis, editors S.E. Papapoulos, Elsevier Science B.V., 1996. P. 341−358.
- Shepherd A.J., Cass A.R., Carlson C.A., et al. Development and internal validation of the male osteoporosis risk estimation score. Ann. Fam. Med. 2007. V. 5. P. 540 546.
- Silman A.J. Risk factors for Colles' fracture in men and women: results from the European Prospective Osteoporosis Study. Osteoporos Int. 2003. Vol. 14. P. 213−218.
- Simpson E.R. Sources of estrogen and their importance. J. Steroid Bioch. Molec. Biol. 2003. V. 86. P. 225−230.
- Simpson E.R., Rubin G., Clyne C., et al. The role of local estrogen biosynthesis in males and females. Trends Endocrin. Metab. 2000. V. 11. P. 184 188.
- Singer B.R., McLauchlan G.J., Robinson C.M., et al. Epidemiology of fractures in 15,000 adults: the influence of age and gender. J. Bone. Joint Surg. Br. 1998. V. 80. P. 243−248.
- Slemenda C.W., Longcope C., Zhou L., et al. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J. Clinic. Investig. 1997. V. 100. P. 1755−1759.
- Smith E.P., Boyd J., Frank G.R., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England J. Med. 1994. V. 331. P. 1056−1061.
- Snyder P.J., Peachey H., Berlin J.A., et al. Effects of testosterone replacement in hypogonadal men. J. Clinic. Endocrin. Metab. 2000. V. 85. P. 26 702 677.
- Soroco S., Barren Connor E.L., Edelslein S.L., et al. Family history of osteoporosis and bone mineral density at the axial skeleton. J. Bone Miner. Res. 1997. V. 12. N l.P. 16−23.
- Stanley H.L., Schmitt B.P., Poses R.M., et al. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J. Amer. Geriatrics Soc.1991. V. 39. P. 766−771.
- Stauber M., Muller R. Age-related changes in trabecular bone microstructures: global and local morphometry. Osteoporosis Int. 2006. Vol. 17. № 4. P.616 626.
- Stein E., Shane E. Secondary osteoporosis. Endocrinol. Metab. Clin. North. Am. 2003. Vol. 32. P. 115−134.
- Stevens J.A., Sogolow E.D. Gender differences for non-fatal unintentional fall related injuries among older adults. Inj Prev. 2005. V. l 1. P. 115−119.
- Swerdloff R.S., Wang C. Androgens and the aging male. In Textbook of Men’s Health, pp 148−157. Eds B Lunenfeld & L Gooren. New York, NY: Parthenon Publishing Group, 2002.
- Szulc P., Munoz F., Claustrat B., et al. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J. Clinic. Endocrin. Metab. 2001. V. 86. P. 192−199.
- Szulc P., Munoz F., Marchand F., et al. Longitudinal evatution of bone loss in elderly men. The MINOS study. Osteoporosis International. 2005. V. 11, Supp.2, SI67.
- Taxel P., Kennedy D.G., Fall P.M., et al. The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. J. Clinic. Endocrin. Metab. 2001. V. 86. P. 2869−2874.
- Thomas-John M., Codd M.B., Manne S., et al. Risk factors for the development of osteoporosis and osteoporotic fractures among older men. J. Rheumatol. 2009. V. 36. P. 1947 1952.
- Tracz M.J., Sideras K., Bolona E.R., et al. Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J. Clin. Endocrinol. Metab. 2006. V. 91. P. 2011 -2016.
- Vandenput L., Swinnen J.V., Boonen S., et al. Role of the androgen receptor in skeletal homeostasis: the androgen-resistant testicular feminized male mouse model. J. Bone Miner. Res. 2004. V. 19. P. 1462−1470.
- Vanderschueren D., Bouillon R. Androgens and bone. Calcif. Tissue Int. 1995. V. 56. P. 341−346.
- Vanderschueren D., Vandenput L., Boonen S., et al. Androgens and bone. Endocrine Reviews. 2004. V. 25. P. 389−425.
- Vermeulen A., Kaufman J.M., Goemaere S., et al. Estradiol in elderly men. Aging Male. 2002. V. 5. P. 98−102.
- Ward K.D., Klesges R.C. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif. Tissue Int. 2001. Vol.68. P. 259−270.
- Xu S.Z., Huang W.M., Ren J.Y. The new model of age-dependent changes in bone mineral density. Growth Dev. Aging. 1997. V. 61. N 1. P. 19−26.
- Yan L., Zhou B., Prentice A., et al. Epidemiological study of hip fracture in Shenyang, People’s Republic of China. Bone. 1999. V.4. P. 151−155.
- Ybarra J., Ade R., Romto J.H. Osteoporosis in men: a review. Nars. Clin. North. Am. 1996. V. 31. N4.P. 805−813.119